A few studies of the metabolism and distribution of fibrinogen in healthy men have been reported (1-3), but because of the lability of fibrinogen and the methods employed the earlier of these do not appear to have been entirely successful. Recent advances in the preparation of fibrinogen-131I (4, 5) and in the mathematics of its kinetic behavior (6) have made possible more reliable and extensive studies. Observations have therefore been made on 12 healthy male volunteers with autologous fibrinogen labeled with 125J.
Studies of the Metabolism and Distribution of Fibrinogen in
Healthy Men A few studies of the metabolism and distribution of fibrinogen in healthy men have been reported (1-3), but because of the lability of fibrinogen and the methods employed the earlier of these do not appear to have been entirely successful. Recent advances in the preparation of fibrinogen-131I (4, 5) and in the mathematics of its kinetic behavior (6) have made possible more reliable and extensive studies. Observations have therefore been made on 12 healthy male volunteers with autologous fibrinogen labeled with 125J.
Methods
The subjects, mainly graduate students or janitors, were healthy male volunteers, ranging from 16 to 54 years in age. They took 10 drops of saturated K(I solution three times a day for the 3 days preceding the experiment and 10 drops once daily during the 7 to 9 days of the experiment. The preparation of fibrinogen for labeling was carried out by a minor modification of the method of Atencio, Burdick, and Reeve (4) as follows: About 20 ml plasma, separated from the subject's heparinized blood, was diluted with an equal volume of 0.09 M sodium citrate and recentrifuged for 10 minutes to remove any remaining platelets and red cells. The diluted plasma was mixed with 4 M (NH4)2SO4 (saturated) in a volume ratio of 3 to 1, left at room temperature for 5 minutes, and spun for 5 minutes at 2,000 rpm, and the supernatant was discarded. The precipitate, after washing three times with a total of 120 ml of 1 M (NH4) 2SO4, was dissolved in 15 ml of 0.005 M sodium citrate, reprecipitated with 5 ml of 4 M (NH4)2SO4, and washed once with 40 ml 1 M (NH4)2S04. The fibrinogen was then dissolved in 4 ml of 0.005 M sodium citrate, refrigerated at 4°C for 3 hours, and spun down at 40 C for 20 minutes to remove cold insoluble material. At this stage the clottability of fibrinogen was usually 95%o or greater. If less than 95%o, the fibrinogen was reprecipitated and again washed with 1 M (NH4) 2SO4. The clottability was measured as described elsewhere (4) . The fibrinogen was then labeled with 'I in a ratio of 0.5 or less atoms iodine per molecule of fibrinogen by the iodine monochloride method (4, 5, 7), after which free 'I was removed by repeated precipitation and washing with 1 M (NH4)2SO4. The fibrinogen-w'I was dissolved in 4 ml of 0.005 M sodium citrate, refrigerated for 3 hours, and centrifuged at 3,000 rpm for 20 minutes to remove any cold insoluble material. The amount of free 'I in the fibrinogen-'I preparations was less than 1% of the total radioactivity. The preparation was sterilized by filtration through a Selas filter (FMB-52-03) 1 with a positive pressure of 5 pounds per square inch. One ml of 6 mg per ml human serum albumin 2 in 0.005 M sodium citrate was first passed through the filter and then the fibrinogen-'I mixed with 1 ml of the same albumin solution. The clottability of fibrinogen-1"I did not significantly differ from that of the unlabeled fibrinogen (4) .
The interval between the withdrawal of plasma for preparation of fibrinogen for labeling and the injection of fibrinogen-'I was 24 hours. Five to 15 ucc of fibrinogen-'I in a volume of 4 to 5 ml containing about 5 mg of fibrinogen was injected intravenously into the subjects. The first blood sample was withdrawn 15 minutes and subsequent samples i, i, 1, 2, 3, 4, 5, 6, and 7, and sometimes 8 and 9 days after the injection. Samples were heparinized. Twenty-four-hour urine collections were made daily throughout the experiments. Plasma and urine samples were assayed for radioactivity in a well scintillation counter with spectrometer and a sensitivity of about 7 X 106 cpm per esc of 'I above the background of 50 cpm. The plasma volume was obtained from the total fibrinogen-bound radioactivity injected divided by the counts per minute per milliliter plasma of the 15-minute sample. The plasma fibrinogen concentration was measured daily by the isotope dilution method of Atencio and co-workers (4 The mathematical model used for analysis of the data is fully described elsewhere (6) . The differential equations describing the model and their solutions provide the following rate constants: the fractional catabolic rates of plasma fibrinogen j3p and js. were calculated from jIp= (Cl/a + C2/b)-1, and j3U from j3t = u2,3/42,8(t3 -t2) * (15 -a) /k5, where C1, a, C2, and b are the parameters of a function (x) describing the behavior of plasma fibrinogen-MI, U2,3 is the total radioactivity excreted in the urine during the time interval t2 to t3, 423 is the mean plasma radioactivity during the same interval, and k5 is the daily fractional excretion rate of the breakdown products of fibrinogen-"I through the kidney. Previous observations (8) showed that the mean value of k5 was 2.02 per day. The fractional transcapillary transfer rate of plasma fibrinogen jI was calculated from jI = C1a + C2b -j3. The catabolic and transcapillary fibrinogen fluxes were obtained from j3,R and j,., respectively, where x is the mean total fibrinogen in the plasma. The amount of interstitial fibrinogen, y, was calculated as described previously (9, 10).
Results
Body weight and plasma data. (Table II) .
The function describing the plasma fibrinogen-1251 radioactivity, x, and the cumulative excretion of radioactivity, u. The plasma radioactivities of all samples were expressed as fractions of the 15-minute sample, and these data were analyzed by the method of least squares with the IBM 709 digital computer (11) . The data were closely described by a two-exponential equation of the form, x = Cle-at + C2e-btk The closeness of the fit is demonstrated by the small values of the "variance of the fit" (11) as given in Table II . The values for the parameters of x are also given in Table II , which shows that in the 12 subjects studied the average value is x = 0.82e01207t + 0.18e-3 57t. The results of a typical experiment are shown in Figure 1 . The half-life of the slower component, a, of x varied from 2.78 to 3.65 with a mean value of 3.36 days (Table II) .
The cumulative urinary excretions of radioactivity in all subjects were expressed as fractions of the total radioactivity initially injected. urinary radioactivity curve is shown in Figure 1 . When 1 minus the cumulative urinary excretion of radioactivity, u, is plotted against time, after a day or two in all experiments 1 -u is described by the exponential curve 1 -u = Ce-aut. The parameters C3 and au were determined by the method of least squares by the IBM 709 digital computer (11) . The values of Ca, au, and "the variance of the fit" are given in Table III , which demonstrates that observed 1 -u is closely fitted by the exponential equation 1 -u = C3e-aut.
The radioactivity unbound to fibrinogen in the body, z. This radioactivity was calculated from the counts per minute per milliliter of the supernatant from plasma treated with trichloroacetic acid and corrected for the dilution by the trichloroacetic acid and distribution in the iodide space.
The latter was taken as 31%o of body weight (8) . The radioactivity so calculated was expressed as a fraction of the total radioactivity injected. A typical z curve is shown in Figure 1 . Mean values for z with their standard deviations for seven subjects at 0, i, j, 1, 2, 3, 4, 5, 6, and 7 days after injection of fibrinogen-'25I were 0.02 + 0.01, 0.03 + 0.01, 0.05 ± 0.02, 0.09 ± 0.03, 0.08 ± 0.01, 0.05 + 0.01, 0.05 ± 0.01, 0.04 ± 0.01, 0.03 ± 0.01, and 0.03 ± 0.01, respectively. Thus z rises rapidly, reaches its maximal value on the first day, and thereafter declines at an exponential rate, paralleling the rate of decline of the plasma fibrinogen-1251I radioactivity. However, the radioactivity unbound to fibrinogen in the plasma never exceeded 2%o of the total plasma fibrinogen radioactivity.
Calculation of the fractional rates and fibrinogen fluxes. It was shown by Atencio, Bailey, and Reeve (6) that whether or not the animal fibrinogen system was in a steady state, as evidenced by fluctuations or lack of fluctuations of plasma fibrinogen concentration, the fractional rates for fibrinogen breakdown and transcapillary transfer and fibrinogen fluxes could be calculated from the tracer data provided these showed certain characteristics. First, the plasma fibrinogen-125I radioactivity x must be described by an exponential equation of the form x = C1e-at + C2e-bt; second, after a day or two the curve describing 1 -u must be described by an exponential equation of the form 1 -u = C3eQat with au close in numerical value to a. Further characteristics are that the data describing the downslope of the z curve should be described by z = Ce-azt and that a, should also be close to a. Another requirement is that the observed values of 1 -u, z, and the extravascular fibrinogen radioactivity (y) should closely agree with those predicted by the model of fibrinogen metabolism (6) . (Table  IV) .
Interstitial fibrinogen, 9 ¶, and its passage time distribution through the interstitial fluids, F ( T). Elsewhere (9, 10) the interstitial albumin is pictured as flowing through an innumerable number of tubes with varying passage times, and the passage time distribution [F(T)] of these tubes, namely that of interstitial albumin, is derived with the plasma albumin specific activity curve. This being the case, -the total amount of interstitial albumin can be calculated from jkJfjo F(T)dT, where jx is the inflow of albumin into the interstitial fluids (9, 10) . By these methods the interstitial fibrinogen y was calculated, which averaged 24.0 mg per kg body weight with a range of from 11.6 to 38.6. The ratio of the interstitial to the intravascular fibrinogen ranged from 0.102 to 0.266 with a mean value of 0.188 (Table IV) . When the plasma fibrinogen radioactivity curve is a two-exponential function, the passage time distribution of y through the interstitial fluids is a single exponential function, F(T) = e-dT (9, 10), and day, and 90%o by 1 day. However, the calculation of the fraction of y that requires passage times through the interstitial fluids greater than i, 1, A, a, and 1 day (9, 10) showed that they were 94, 83, 60, 43, and 29%o, respectively. Thus, the major part of the fibrinogen flux passes rapidly through the interstitial fluids, but the major fraction of the interstitial fibrinogen is in slower passage through the interstitial fluids.
Discussion
The present studies were carried out in residents of Denver at an altitude of 5,280 feet. The average plasma fibrinogen concentration was 3.60 + 0.5 mg per ml. This is considerably higher than the average value of 2.5 mg per ml for residents at sea level (13) . The isotope dilution method used for making the measurements has been thoroughly studied elsewhere (4) , and the raised plasma fibrinogen levels in healthy Denver residents have been confirmed by another method (13) .
The user of iodinated proteins for metabolic studies always has to provide evidence that the iodination has not altered the metabolism of the protein.
In animal experiments comparisons can be made with proteins "biologically" labeled (5) or with "screened" proteins (5), but this is not possible in man. The following arguments, however, indicate that the 125I-labeled fibrinogens used were satisfactory. Preparations made in similar circumstances (3, 14) behave satisfactorily in rabbits. The fibrinogen preparations averaged 96% in clottability, and ultracentrifugal analysis ( Figure 2) C1, early accumulation of free 125I in the plasma with resulting high z values, and early urinary excretion of 125I at an increased rate (15) . None of these findings were seen in the present study. C1 averaged the high value of 0.82 (Table II) , plasma free 125I never exceeded 2% of the total plasma fibrinogen radioactivity, and j3,,, which is equivalent to Berson's degradation rate (15) , was minimal during the first day and thereafter remained constant (Figure 1 ). Another test may be used with the fibrinogen-125I. It prolapse that agree closely with ours. The present study does not provide clues as to how fibrinogen is catabolized, namely, whether it is broken down directly or after fibrin formation, or by both paths. However, mathematical considerations described below provide some information. Elsewhere (6) the fibrinogen system is described by six differential equations, but when assumed that the fibrin-131I [w (t) ] and the fibrinogen-131I at the catabolic site [v(t) ] were negligibly small or nonexistent, or their respective fractional catabolic rates j5 and k6 were very large if both w(t) and v(t) were present in significant amounts, the fibrinogen system can be described by four differential equations. The validity of these assumptions may be tested by comparing the observed values of the breakdown products of fibrinogen-125I (z), the cumulative radioactivities excreted in the urine (u), and the extravascular fibrinogen-125I (y) obtained from y = 1 -x -z -u with those values predicted by the four differential equations describing the simplified model. The analysis showed that the observed values of z and y agreed closely with those predicted by the equations, and as shown in Figure 3 
Summary
Fibrinogen averaging 96% clottability was prepared from the subjects' own plasma by repeated salt fractionation with I saturated ammonium sulfate and labeled with 125I in a ratio of 0.5 or less atoms iodine per molecule of fibrinogen. With this preparation, studies were made of the metabolism and distribution of fibrinogen in 12 healthy male subjects.
The results of the present studies were as follows: The average value for the plasma volume was 35.6 ± 3.5 ml per kg; for the plasma fibrinogen concentration, 360 + 50 mg per 100 ml; for the intravascular fibrinogen, 127 ± 17 mg per kg; for the interstitial fibrinogen, 24.0 + 6.8 mg per kg; for the slower half-life of fibrinogen-125_, 3 .36 ± 0.25 days; for the transcapillary transfer rate of fibrinogen, 69.0 ± 35.3 mg per kg per day; and for the catabolic rate of fibrinogen, 31.3 + 5.0 mg per kg per day.
These studies are compared with those of previous investigators, and criteria of satisfactory behavior of fibrinogen-311I are examined. The kinetic data indicate that in healthy individuals fibrinogen is either catabolized directly with insignificant fibrin formation or that if significant amounts of fibrin are formed these are broken down almost instantaneously. Also it was shown that fibrinogen is catabolized intravascularly or at sites in rapid exchange with the vascular compartment.
